Based on my reading and in consultation with many colleagues, here is my current take on the landscape of Drug Tx for #COVID19:
Promising:
-Remdesivir, Favipiravir
-IL-6 modulators (in cytokine storm)
-Convalescent plasma
Disappointing:
-Steroids
-Kaletra
-HCQ, Azithro
Promising:
-Remdesivir, Favipiravir
-IL-6 modulators (in cytokine storm)
-Convalescent plasma
Disappointing:
-Steroids
-Kaletra
-HCQ, Azithro
There are 169 drug trials registered with clinicaltrials.gov, including many other drugs not listed above. I included my take on a few of the more popular ones.
Follow them all here: clinicaltrials.gov/ct2/results?te…
Follow them all here: clinicaltrials.gov/ct2/results?te…
A lot of ppl are still holding out hope for HCQ, and all I can say is this, it is by no means a silver bullet. It may have some value, but we need to wait. It is being considered as an early intervention to curb the natural course of dz (ongoing studies at Duke and Minnesota).
